4/A: Stepan Co. Corrects Executive Stock Option Pricing

Stepan Company executive Richard Finn Stepan filed an amendment to correct an administrative error regarding the exercise price of stock appreciation rights.

Summary

• This Form 4/A amends a previous filing from March 4, 2026, for Richard Finn Stepan, V.P. and General Manager of Polymers.
• The amendment corrects the exercise price of Stock Appreciation Rights (SARs) granted on March 2, 2026.
• The exercise price was corrected from $17.47 to $50.06.
• The filing also confirms the acquisition of 56.765 shares of common stock at $52.51 per share on February 27, 2026.
• New equity grants include 4,994 Restricted Stock Units (RSUs) and 2,497 Performance Shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update; the correction of a clerical error does not change the company's financial outlook or strategic direction.

Positives

• Transparency in correcting administrative errors promptly.
• Continued alignment of executive interests with shareholders through equity-based compensation.

Negatives

• Administrative error in the original filing regarding the pricing of derivative securities.

Risks

• Market volatility affecting the value of granted stock appreciation rights and performance shares.
• Performance-based vesting conditions for performance shares may not be met.

Future Outlook

The filing outlines future vesting schedules for RSUs and SARs beginning March 2, 2027, and performance goals for performance shares to be certified for the period ending December 31, 2028.

Management Comments

• The amendment corrects the reported conversion/exercise price due to an administrative error in the pricing calculation.

Industry Context

StockSavvy.ai notes that administrative amendments to SEC filings are common and generally do not reflect underlying operational issues, but rather clerical oversight in reporting complex compensation structures.

Comparison to Industry Standards

• The use of RSUs and performance-based equity is standard practice for executive compensation in the specialty chemicals sector.
• The vesting schedule of three years is consistent with industry norms for retention and long-term incentive alignment.

Stakeholder Impact

• Minimal impact on shareholders as the filing is a clerical correction of an executive's personal holdings.

Next Steps

• Vesting of RSUs and SARs starting March 2, 2027.
• Certification of performance goals for performance shares by December 31, 2028.

Key Dates

Keywords

Stepan Company, SCL, Form 4/A, Insider Trading, Executive Compensation, Polymers